Insulin-like growth factor I increases bone formation in old or corticosteroid treated rats

Acta Orthopaedica Scandinavica

Volumn 68, Issue 6, 1997, Pages 586-592

  Prisell, Per T ^a,b   Aspenberg, Per ^c   Wikström, Bo ^a   Wredmark, Torsten ^a   Norstedt, Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTICOSTEROID; DEXAMETHASONE; HYALURONIC ACID; SOMATOMEDIN C;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; CALCIUM BONE LEVEL; CONTROLLED STUDY; DRUG EFFECT; IMPLANT; MALE; NONHUMAN; OSSIFICATION;

EID: 0031449155     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679708999032     Document Type: Article

References (32)

1. Aspenberg P, Lohmander L S. Fibroblast growth factor stimulates bone formation. Bone induction studied in rats. Acta Orthop Scand 1989; 60: 473-6.
2. Aspenberg P, Wang J-S. Basic fibroblast growth factor and bone induction in rats. Acta Orthop Scand 1993; 5: 557-61.
3. Aspenberg P, Albrektsson T, Thorngren K G. Local application of growth factor IGF-1 to healing bone. Experiments with a titanium chamber in rabbits. Acta Orthop Scand 1989; 60: 607-10.
4. Aspenberg P, Thorngren K G, Lohmander L S. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop Scand 1991; 62: 481-4.
5. Baylink D J, Finkelman R D, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res (Suppl 2) 1993; 8: 565-72.
6. Conover C A., Divertie G D, Lee P D. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol 1993; 128: 140-3.
7. D'Costa A P, Ingram R L, Lenham J E, Sonntag W E. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J Reprod Fertil Suppl 1993; 46: 87-98.
8. DiCesare P E, Nimni M E, Peng L, Yazdi M, Cheung D T. Effects of indomethacin on demineralized bone-induced heterotopic ossification in the rat. J Orthop Res 1991; 9: 855-61.
9. Eriksen E F, Kassem M, Brixen K. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res 1993; 40: 95-8.
10. Ezzat S, Smyth H S, Ramyar L, Asa S L. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 1995; 80: 878-84.
11. Fraker P J, Speck J C, Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
12. Howes R, Bowness J M, Grotendorst G R, Martin G R, Reddi A H. Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation. Calcif Tissue Int 1988; 42: 34-8.
13. Hulth A. Current conceps of fracture healing. Clin Orthop 1989; 249: 265-84.
14. Irving J T, LeBolt S A, Schneider E L. Ectopic bone formation and aging. Clin Orthop 1981; 154: 249-53.
15. Jones J I, Clemmons D R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
16. Ku P T, D'Amore P A. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biochem 1995; 58: 328-43.
17. Loveridge N, Farquharson C. Studies on growth plate chondrocytes in situ: cell proliferation and differentiation. Acta Paediatr Supplement 1993; 391: 42-8.
18. McCarthy T L, Centrella M, Canalis E. Insulin-like growth factor (IGF) and bone. Connect Tissue Res 1989; 20: 277-82.
19. McCarthy T L, Centrella M, Raisz L G, Canalis E. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991; 128: 2895-900.
20. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman R D, Baylink D J, Farley J R. Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 1994; 78: 1011-6.
21. Passey R B, Maluf K C. Foundations for validation of quantitative analytical methods in the clinical laboratory. Arch Pathol Lab Med 1992; 116: 732-8.
22. Prisell P T, Camber O, Hiselius J, Norstedt G. Evaluation of hyaluronan as vehicle for peptide growth factors. Int J Pharm 1992; 85: 51-6.
23. Prisell P T, Edwall D, Lindblad J B, Levinovitz A, Norstedt G. Expression of insulin-like growth factors during bone induction in rat. Calcif Tissue Int 1993; 53: 201-5.
24. Reddi A H. Age-dependent decline in extracellular matrix-induced local bone differentiation. Isr J Med Sci 1985; 21: 312-3.
25. Reddi A H, Anderson W A. Collagenous bone matrix-induced endochondral ossification hemopoiesis. J Cell Biol 1976; 69: 557-72.
26. Reddi A H, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci U S A 1972; 69: 1601-5.
27. Reddi A H, Huggins C B. Formation of bone marrow in fibroblast-transformation ossicles. Proc Natl Acad Sci U S A 1975; 72: 2212-6.
28. Sampath T K, Reddi A H. Importance of geometry of the extracellular matrix in endochondral bone differentiation. J Cell Biol 1984; 98: 2192-7.
29. Scutt A, Bertram P. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 1995; 10: 474-87.
30. Topert M. Perspectives in corticosteroid research. Drugs 1988; 5: 1-8.
31. Törnkvist H, Bauer F C, Lindholm T S, Nilsson O S. The osteo-inductive properties of bone matrix from rats pretreated with indomethacin. Scand J Rheumatol 1985a; 14: 197-200.
32. Urist M R. Bone: formation by autoinduction. Science 1965; 150: 893-9.